Results 121 to 130 of about 114,121 (257)
Intelligent design of artificial biocatalyst for biomedical diseases
This review summarizes recent advances in the intelligent design of artificial biocatalysts for biomedical diseases. By leveraging tailored design strategies, including environment‐responsive engineering and rational/artificial intelligence‐aided optimization, these biocatalysts enable precise modulation of pathological microenvironments and targeted ...
Lijie Zhang +3 more
wiley +1 more source
Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome. [PDF]
Chen J +6 more
europepmc +1 more source
Deep learning‐assisted design of nanozyme for immune regulation
Overview of nanozyme‐based strategies for inflammatory bowel disease therapy, featuring metal‐based and non‐metallic nanozymes classified by structure, alongside multifunctional and engineered probiotic‐based nanozymes classified by function. Abstract Inflammatory bowel disease (IBD), with rising global incidence and disease burden, is a multifactorial
Ke Chen +3 more
wiley +1 more source
Abstract Diseases of the Gastrointestinal (GI) tract significantly affect the quality of human life and have a high fatality rate. Accurate diagnosis of GI diseases plays a pivotal role in healthcare systems. However, processing large amounts of medical image data can be challenging for radiologists and other medical professionals, increasing the risk ...
Muhammad Nouman Noor +5 more
wiley +1 more source
Semaglutide-Induced Symptomatic Remission in Ulcerative Colitis. [PDF]
Alqinai B +3 more
europepmc +1 more source
Abstract The GLIM malnutrition diagnostic framework includes the etiologic criterion for reduced dietary intake or assimilation (i.e., digestion or absorption). This criterion required further specification to support consistent use in clinical practice.
Renée Blaauw +28 more
wiley +1 more source
Distinct microbial mediators link diet to inflammation in Crohn's disease and ulcerative colitis. [PDF]
Mayorga L +10 more
europepmc +1 more source
Abstract Objectives The increasing incidence of inflammatory bowel disease (IBD) in paediatric populations underscores the importance of effective management strategies. Anti–tumor necrosis factor (anti‐TNF) agents, such as infliximab (IFX) and adalimumab (ADL), are key treatments for inducing and maintaining remission in IBD, but many patients ...
Karlotta Pauline Hubert +2 more
wiley +1 more source
GPX7 marks fibroblast-associated stromal-innate immune crosstalk in ulcerative colitis. [PDF]
He J, Chen R, Qiu S, Li P, Gao X.
europepmc +1 more source
Spatial Organization of Fibrosis in Stricturing Crohn's Disease
iLABMED, EarlyView.
Wenyu Zhang, Changwei Duan, Xianzong Ma
wiley +1 more source

